Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 18 ($0.22) and traded as low as GBX 12.50 ($0.16). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.22), with a volume of 73,672 shares trading hands.
Biodexa Pharmaceuticals Price Performance
The stock has a market cap of £31.20 million, a P/E ratio of -21.95 and a beta of 1.22. The company has a 50 day simple moving average of GBX 18 and a 200 day simple moving average of GBX 18. The company has a current ratio of 5.28, a quick ratio of 5.28 and a debt-to-equity ratio of 9.52.
Biodexa Pharmaceuticals Company Profile
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Recommended Stories
- Five stocks we like better than Biodexa Pharmaceuticals
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- The Charles Schwab Company Can Hit New Highs
- What Is WallStreetBets and What Stocks Are They Targeting?
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Investing In Preferred Stock vs. Common Stock
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.